Artrya Limited (ASX:AYA)
Australia · Delayed Price · Currency is AUD 2.250
-0.050 (-2.17%)
Sep 26, 2025, 4:10 PM AEST
Artrya Market Cap
Artrya has a market cap or net worth of 332.60 million as of September 26, 2025. Its market cap has increased by 1,308.67% in one year.
Market Cap
332.60M
Enterprise Value
321.90M
Revenue
28.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
2.25
Market Cap Chart
Since November 26, 2021, Artrya's market cap has increased from 119.12M to 332.60M, an increase of 179.21%. That is a compound annual growth rate of 30.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 332.60M | 586.00% |
| Dec 31, 2024 | 48.48M | 156.86% |
| Dec 29, 2023 | 18.88M | -39.81% |
| Dec 30, 2022 | 31.36M | -69.23% |
| Dec 31, 2021 | 101.94M | -14.43% |
| Nov 26, 2021 | 119.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 95.78B |
| Pro Medicus | 32.31B |
| Cochlear | 18.65B |
| Sonic Healthcare | 10.45B |
| Ramsay Health Care | 7.37B |
| Telix Pharmaceuticals | 5.20B |
| Ansell | 4.57B |
| Mesoblast | 3.19B |